On the other hand, the same study showed that in all the cytokines tested, it was the circulating IL-6 level (HR 1.10, 95%CI 1.05–1.16, p < 0.001) that was the most significantly correlated with poor overall survival in glioma patients. Here, IL6 is linked to central nervous system cancer.